Inhibition of MDK, a gene highly expressed in SLS cells, enhanced rapamycin’s therapeutic effect both in vitro and in vivo, suggesting that MDK may at least partially account for the molecular mechanism of rapamycin tolerance in TSC, in line with role of MDK in drug resistance observed in other cancers77,108. This evidence concerns the gene MDK and tuberous sclerosis.